{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:18:29Z","timestamp":1776305909671,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017M3A9B8069530"],"award-info":[{"award-number":["NRF-2017M3A9B8069530"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1A2A2A01004310"],"award-info":[{"award-number":["NRF-2015R1A2A2A01004310"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3031-y","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:35:52Z","timestamp":1522794952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar"],"prefix":"10.1186","volume":"18","author":[{"given":"Jinyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Im","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojong","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u01b0\u01a1ng Giang","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u1ecb Lam","family":"Th\u00e1i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woon-Mok","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe Kyaw","family":"Myint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Kuk","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"3031_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"3031_CR2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0888-7543(91)90465-Q","volume":"10","author":"EY Chen","year":"1991","unstructured":"Chen EY, Cheng A, Lee A, Kuang WJ, Hillier L, Green P, Schlessinger D, Ciccodicola A, D\u2019Urso M. Sequence of human glucose-6-phosphate dehydrogenase cloned plasmids and a yeast artificial chromosome. Genomics. 1991;10:792\u2013800.","journal-title":"Genomics"},{"key":"3031_CR3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/bcmd.2002.0490","volume":"28","author":"E Beutler","year":"2002","unstructured":"Beutler E, Vulliamy T. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 2002;28:93\u2013103.","journal-title":"Blood Cells Mol Dis"},{"key":"3031_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","volume":"48","author":"A Minucci","year":"2012","unstructured":"Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the \u201cold\u201d and update of the new mutations. Blood Cells Mol Dis. 2012;48:154\u201365.","journal-title":"Blood Cells Mol Dis"},{"key":"3031_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM199101173240306","volume":"324","author":"E Beutler","year":"1991","unstructured":"Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991;324:169\u201374.","journal-title":"N Engl J Med"},{"key":"3031_CR6","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","volume":"84","author":"E Beutler","year":"1994","unstructured":"Beutler E. G6PD deficiency. Blood. 1994;84:3613\u201336.","journal-title":"Blood"},{"key":"3031_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133\u2013201.","journal-title":"Adv Parasitol"},{"key":"3031_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/376246a0","volume":"376","author":"C Ruwende","year":"1995","unstructured":"Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AV. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246\u20139.","journal-title":"Nature"},{"issue":"8","key":"3031_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s001090050253","volume":"76","author":"C Ruwende","year":"1998","unstructured":"Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med (Berl). 1998;76(8):581.","journal-title":"J Mol Med (Berl)"},{"key":"3031_CR10","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"911","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;911:e1001339.","journal-title":"PLoS Med"},{"key":"3031_CR11","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1178849","volume":"326","author":"C Louicharoen","year":"2009","unstructured":"Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in southeast Asians. Science. 2009;326:1546\u20139.","journal-title":"Science"},{"key":"3031_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0140-6736(72)90676-9","volume":"1","author":"U Bienzle","year":"1972","unstructured":"Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet. 1972;1:107\u201310.","journal-title":"Lancet"},{"key":"3031_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1061573","volume":"293","author":"SA Tishkoff","year":"2001","unstructured":"Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001;293:455\u201362.","journal-title":"Science"},{"key":"3031_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4269\/ajtmh.2003.68.186","volume":"68","author":"LE Mombo","year":"2003","unstructured":"Mombo LE, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, Krishnamoorthy R. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese school children. Am J Trop Med Hyg. 2003;68:186\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"3031_CR15","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1371\/journal.pmed.0040066","volume":"4","author":"A Guindo","year":"2007","unstructured":"Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007;4:e66.","journal-title":"PLoS Med"},{"key":"3031_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pt.2010.08.005","volume":"27","author":"JK Barid","year":"2011","unstructured":"Barid JK, Surjadjaja C. Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2011;27:11\u20136.","journal-title":"Trends Parasitol"},{"key":"3031_CR17","volume-title":"Strategy for malaria elimination in the greater Mekong subregion (2015\u20132030)","author":"WHO","year":"2015","unstructured":"WHO. Strategy for malaria elimination in the greater Mekong subregion (2015\u20132030). Geneva: World Health Organization; 2015."},{"key":"3031_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12936-015-0787-z","volume":"14","author":"Malaria Policy Advisory Committee to the WHO","year":"2015","unstructured":"Malaria Policy Advisory Committee to the WHO. conclusions and recommendations of seventh biannual meeting (March 2015). Malar J. 2015;14:295.","journal-title":"Malar J"},{"key":"3031_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10038-004-0187-7","volume":"49","author":"H Matsuoka","year":"2004","unstructured":"Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T, Jalloh A, Lin K, Kawamoto F. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population. J Hum Genet. 2004;49:544\u20137.","journal-title":"J Hum Genet"},{"key":"3031_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10038-007-0217-3","volume":"53","author":"I Nuchprayoon","year":"2008","unstructured":"Nuchprayoon I, Louicharoen C, Charoenvej W. Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar. J Hum Genet. 2008;53:48\u201354.","journal-title":"J Hum Genet"},{"key":"3031_CR21","doi-asserted-by":"crossref","first-page":"e116063","DOI":"10.1371\/journal.pone.0116063","volume":"9","author":"G Bancone","year":"2014","unstructured":"Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, White NJ, Nosten FH. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border. PLoS One. 2014;9:e116063.","journal-title":"PLoS One"},{"key":"3031_CR22","doi-asserted-by":"crossref","first-page":"e0134593","DOI":"10.1371\/journal.pone.0134593","volume":"10","author":"Q Li","year":"2015","unstructured":"Li Q, Yang F, Liu R, Luo L, Yang Y, Zhang L, Liu H, Zhang W, Fan Z, Yang Z, Cui L, He Y. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency at the China-Myanmar border. PLoS One. 2015;10:e0134593.","journal-title":"PLoS One"},{"key":"3031_CR23","doi-asserted-by":"crossref","first-page":"e0152304","DOI":"10.1371\/journal.pone.0152304","volume":"11","author":"NN Oo","year":"2016","unstructured":"Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, Htun MM, Thant KZ, Htut Y, Nosten F. Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar. PLoS One. 2016;11:e0152304.","journal-title":"PLoS One"},{"key":"3031_CR24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12936-017-1765-4","volume":"16","author":"JM Kang","year":"2017","unstructured":"Kang JM, Cho PY, Moe M, Lee J, Jun H, Lee HW, Ahn SK, Kim TI, Park JH, Myint MK, Lin K, Kim TS, Na BK. Comparison of the diagnostic performance of microscopic examination with nested polymerase chain reaction for optimum malaria diagnosis in upper Myanmar. Malar J. 2017;16:119.","journal-title":"Malar J"},{"key":"3031_CR25","volume":"10","author":"Q Peng","year":"2015","unstructured":"Peng Q, Li S, Ma K, Li W, Ma Q, He X, He Y, He T, Lu X. Large cohort screening of G6PD deficiency and the mutational spectrum in the Dongguan District in Southern China. PLoS One. 2015;10:e0120683.","journal-title":"PLoS One"},{"key":"3031_CR26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12936-016-1392-5","volume":"15","author":"ST Thein","year":"2016","unstructured":"Thein ST, Sudhinaraset M, Khin HS, McFarland W, Aung T. Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar. Malar J. 2016;15:334.","journal-title":"Malar J"},{"key":"3031_CR27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40249-016-0130-0","volume":"5","author":"M Kotepui","year":"2016","unstructured":"Kotepui M, Uthaisar K, PhunPhuech B, Phiwklam N. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients. Infect Dis Poverty. 2016;5:36.","journal-title":"Infect Dis Poverty"},{"key":"3031_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1475-2875-12-171","volume":"12","author":"N Khim","year":"2013","unstructured":"Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, M\u00e9nard D. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J. 2013;12:171.","journal-title":"Malar J"},{"key":"3031_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.1977.tb00589.x","volume":"35","author":"E Beutler","year":"1977","unstructured":"Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol. 1977;35:331\u201340.","journal-title":"Br J Haematol"},{"key":"3031_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2141.1985.tb07385.x","volume":"60","author":"CJ Van Noorden","year":"1985","unstructured":"Van Noorden CJ, Vogels IM. A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency. Br J Haematol. 1985;60:57\u201363.","journal-title":"Br J Haematol"},{"key":"3031_CR31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood.V32.5.816.816","volume":"32","author":"E Beutler","year":"1968","unstructured":"Beutler E, Mitchell M. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood. 1968;32:816\u20138.","journal-title":"Blood"},{"key":"3031_CR32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.1995.tb04095.x","volume":"48","author":"P Ninfali","year":"1995","unstructured":"Ninfali P, Baronciani L, Bardoni A, Bresolin N. Muscle expression of glucose-6-phosphate dehydrogenase deficiency in different variants. Clin Genet. 1995;48:232\u20137.","journal-title":"Clin Genet"},{"key":"3031_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0969-2126(00)00104-0","volume":"8","author":"SW Au","year":"2000","unstructured":"Au SW, Gover S, Lam VM, Adams MJ. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency. Structure. 2000;8:293\u2013303.","journal-title":"Structure"},{"key":"3031_CR34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2007.08.122","volume":"93","author":"Y Huang","year":"2008","unstructured":"Huang Y, Choi MY, Au SW, Au DM, Lam VM, Engel PC. Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD (Plymouth) and G6PD (Mahidol): evidence for defective protein folding as the basis of disease. Mol Genet Metab. 2008;93:44\u201353.","journal-title":"Mol Genet Metab"},{"key":"3031_CR35","doi-asserted-by":"crossref","first-page":"21179","DOI":"10.3390\/ijms151121179","volume":"15","author":"S G\u00f3mez-Manzo","year":"2014","unstructured":"G\u00f3mez-Manzo S, Terr\u00f3n-Hern\u00e1ndez J, De la Mora-De la Mora I, Gonz\u00e1lez-Valdez A, Marcial-Quino J, Garc\u00eda-Torres I, Vanoye-Carlo A, L\u00f3pez-Vel\u00e1zquez G, Hern\u00e1ndez-Alc\u00e1ntara G, Oria-Hern\u00e1ndez J, Reyes-Vivas H, Enr\u00edquez-Flores S. The stability of G6PD is affected by mutations with different clinical phenotypes. Int J Mol Sci. 2014;15:21179\u2013201.","journal-title":"Int J Mol Sci"},{"key":"3031_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2016.03.008","volume":"118","author":"U Boonyuen","year":"2016","unstructured":"Boonyuen U, Chamchoy K, Swangsri T, Saralamba N, Day NP, Imwong M. Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: decreased stability and catalytic efficiency contribute to the clinical phenotype. Mol Genet Metab. 2016;118:84\u201391.","journal-title":"Mol Genet Metab"},{"key":"3031_CR37","first-page":"601","volume":"67","author":"WHO Working Group","year":"1989","unstructured":"WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601\u201311.","journal-title":"Bull World Health Organ"},{"key":"3031_CR38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/bcmd.1997.0147","volume":"23","author":"T Bulliamy","year":"1997","unstructured":"Bulliamy T, Luzzatto L, Hirono A, Beutler E. Hematologically important mutations: Glucose-6-phosphate dehydrogenase. Blood Cells Mols Dis. 1997;23:302\u201313.","journal-title":"Blood Cells Mols Dis"},{"key":"3031_CR39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1475-2875-9-332","volume":"9","author":"AK Kone","year":"2010","unstructured":"Kone AK, Sagara I, Thera MA, Dicko A, Guindo A, Diakite S, Kurantsin-Mills J, Djimde A, Walcourt A, Doumbo O. Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali. Malar J. 2010;9:332.","journal-title":"Malar J"},{"key":"3031_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1475-2875-10-241","volume":"10","author":"N Carter","year":"2011","unstructured":"Carter N, Pamba A, Duparc S, Waitumbi JN. Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials. Malar J. 2011;10:241.","journal-title":"Malar J"},{"key":"3031_CR41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0035-9203(94)90306-9","volume":"88","author":"K Na-Bangchang","year":"1994","unstructured":"Na-Bangchang K, Sahasaeng W, Thanavibul A, Charoenlarp P, Karbwang J. Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria. Trans R Soc Trop Med Hyg. 1994;88:220\u20132.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3031_CR42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10038-005-0279-z","volume":"50","author":"H Matsuoka","year":"2005","unstructured":"Matsuoka H, Nguon C, Kanbe T, Jalloh A, Sato H, Yoshida S, Hirai M, Arai M, Socheat D, Kawamoto F. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population. J Hum Genet. 2005;50:468\u201372.","journal-title":"J Hum Genet"},{"key":"3031_CR43","first-page":"213","volume":"61","author":"H Matsuoka","year":"2007","unstructured":"Matsuoka H, Thuan DT, van Thien H, Kanbe T, Jalloh A, Hirai M, Arai M, Dung NT, Kawamoto F. Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in lam Dong Province in southern Vietnam. Acta Med Okayama. 2007;61:213\u20139.","journal-title":"Acta Med Okayama"},{"key":"3031_CR44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1475-2875-12-289","volume":"12","author":"RP Nantakomol","year":"2013","unstructured":"Nantakomol RP, Attakorn P, Day NPJ, White NJ, Imwong M. Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency Duangdao. Malar J. 2013;12:289.","journal-title":"Malar J"},{"key":"3031_CR45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.trsl.2014.09.009","volume":"165","author":"JK Baird","year":"2015","unstructured":"Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015;165:677\u201388.","journal-title":"Transl Res"},{"key":"3031_CR46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4269\/ajtmh.14-0696","volume":"92","author":"G Bancone","year":"2015","unstructured":"Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, Bansil P, McGray S, Domingo GJ, Nosten FH. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg. 2015;92:818\u201324.","journal-title":"Am J Trop Med Hyg."},{"key":"3031_CR47","doi-asserted-by":"crossref","first-page":"e116143","DOI":"10.1371\/journal.pone.0116143","volume":"9","author":"A Roca-Feltrer","year":"2014","unstructured":"Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, Tor P, Chuor CM, Kheng S, Siv S, Kachur PS, Taylor WR, Hwang J, Menard D. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One. 2014;9:e116143.","journal-title":"PLoS One"},{"key":"3031_CR48","doi-asserted-by":"crossref","first-page":"e0004457","DOI":"10.1371\/journal.pntd.0004457","volume":"10","author":"AW Satyagraha","year":"2016","unstructured":"Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, Oyong D, Subekti D, Rozi IE, Domingo GJ, Harahap AR, Baird JK. Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural eastern Indonesia. PLoS Negl Trop Dis. 2016;10:e0004457.","journal-title":"PLoS Negl Trop Dis"},{"key":"3031_CR49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12936-016-1140-x","volume":"15","author":"HM Peixoto","year":"2016","unstructured":"Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon. Malar J. 2016;15:82.","journal-title":"Malar J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:27:00Z","timestamp":1571002020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3031-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3031-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"article-number":"131"}}